98%
921
2 minutes
20
With an aging world population, risk stratification of community-based, elderly population is required for primary prevention. This study proposes a combined score developed using electrocardiographic (ECG) parameters and determines its long-term prognostic value for predicting risk of cardiovascular mortality. A cohort-study, conducted from December 2008 to April 2019, enrolled 5,380 subjects in Taiwan, who were examined, using three-serial-12-lead ECGs, and their health/demographic information were recorded. To understand the predictive effects of ECG parameters on overall-survival, Cox hazard regression analysis were performed. The mean age at enrollment was 69.04 ± 8.14 years, and 47.4% were males. ECG abnormalities, LVH [hazard ratio (HR) = 1.39, 95% confidence intervals (CI) = (1.16-1.67), = 0.0003], QTc [HR = 1.31, CI = (1.07-1.61), = 0.007] and PR interval [HR = 1.40, CI = (1.01-1.95), = 0.04], were significantly associated with primary outcome all-cause death. Furthermore, LVH [HR = 2.37, CI = (1.48-3.79), = 0.0003] was significantly associated with cardiovascular death, while PR interval [HR = 2.63, CI = (1.24- 5.57), = 0.01] with unexplained death. ECG abnormality (EA) score was defined based on the number of abnormal ECG parameters for each patient, which was used to divide all patients into sub-groups. Competing risk survival analysis using EA score were performed by using the Gray's test, which reported that high-risk EA groups showed significantly higher cumulative incidence for all three outcomes. Prognostic models using the EA score as predictor were developed and a 10-fold cross validation design was adopted to conduct calibration and discrimination analysis, to establish the efficacy of the proposed models. Overall, ECG model could successfully predict people, susceptible to all three death outcomes ( < 0.05), with high efficacy. Statistically significant ( < 0.001) improvement of the c-indices further demonstrated the robustness of the prediction model with ECG parameters, as opposed to a traditional model with no EA predictor. The EA score is highly associated with increased risk of mortality in elderly population and may be successfully used in clinical practice.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8531436 | PMC |
http://dx.doi.org/10.3389/fcvm.2021.738061 | DOI Listing |
Front Artif Intell
August 2025
School of Electronics Engineering (SENSE), Vellore Institute of Technology, Chennai, India.
Introduction: In recent years, Deep Learning (DL) architectures such as Convolutional Neural Network (CNN) and its variants have been shown to be effective in the diagnosis of cardiovascular disease from ElectroCardioGram (ECG) signals. In the case of ECG as a one-dimensional signal, 1-D CNNs are deployed, whereas in the case of a 2D-represented ECG signal, i.e.
View Article and Find Full Text PDFFront Endocrinol (Lausanne)
September 2025
Department of Medical Sciences, University of Turin, Turin, Italy.
Context: Cardiometabolic complications are increasingly recognized in congenital adrenal hyperplasia (CAH) due to 21β-hydroxylase deficiency, but adult data remain limited.
Objective: To evaluate cardiovascular and metabolic alterations in adult patients with classic CAH under glucocorticoid treatment, compared to matched controls.
Methods: A cross-sectional study was conducted on adults with classic CAH and sex- and BMI-matched controls.
J Electrocardiol
August 2025
Department of Emergency Medicine, Ordu University Faculty of Medicine, Ordu, Türkiye.
Background: Hypertensive crisis (HC) is recognized as a contributing factor in the development of cardiac arrhythmias. This study aims to assess Tp-e interval, Tp-e/QT (TQR), and Tp-e/QTc (TQcR) ratios in patients experiencing hypertensive urgency and emergency, in order to evaluate the potential risk of ventricular arrhythmias.
Methods: A prospective study was conducted involving HC patients admitted to a tertiary hospital's emergency department between June 1, 2022, and June 30, 2024.
J Res Pharm Pract
August 2025
Cardiovascular Research Center, Institute of Basic and Clinical Physiology Sciences, Kerman University of Medical Sciences, Kerman, Iran.
Objective: Methadone treatment is effective for managing opioid use disorder (OUD) but raises concerns about its impact on cardiac function. This study aimed to assess the prevalence of cardiac dysfunction among individuals under methadone treatment.
Methods: This cross-sectional study involved 200 OUD patients admitted to addiction treatment centers of Kerman, Iran, who were at least 1 year under methadone maintenance therapy.
Despite clinical need, no new drugs for treating ventricular tachycardia (VT) have emerged for over 20 years. In structural heart disease, posttranslational modifications render intracellular ryanodine receptor-2 (RyR2) calcium release channels leaky, which increases VT risk. Treatment with dantrolene, an RyR2 inhibitor, prevents VT in animal models.
View Article and Find Full Text PDF